TABLE 2.
Antimicrobial susceptibilities of eight ceftriaxone-resistant Salmonella isolates
| Isolate no. | MICa (μg/ml)
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMP | CRO | CTX | CAZ | FEP | IPM | TZP | CHL | MIN | SXT | CIP | |
| B11 | >128 | 32 | 16 | 32 | 0.5 | 0.25 | 128 | >128 | 64 | >128 | 0.03 |
| B25 | >128 | 64 | 32 | 64 | 4 | 0.25 | 128 | >128 | 32 | >128 | 0.03 |
| L4 | >128 | 64 | 32 | 64 | 4 | 0.25 | 128 | >128 | 64 | >128 | 0.5 |
| L5 | >128 | 32 | 16 | 64 | 0.25 | 0.5 | 16 | 4 | 2 | 0.12 | 0.03 |
| L6 | >128 | 32 | 16 | 64 | 0.5 | 0.25 | 32 | 4 | 4 | >128 | 0.03 |
| L8 | >128 | >128 | >128 | 4 | >128 | 0.25 | 16 | >128 | 32 | >128 | 0.06 |
| L9 | >128 | 64 | 16 | 64 | 8 | 0.5 | 128 | >128 | 32 | >128 | 0.5 |
| L10 | >128 | 64 | 16 | 64 | 1 | 0.25 | 32 | >128 | 8 | >128 | 0.5 |
a
AMP, ampicillin; CRO, ceftriaxone; CTX, cefotaxime; CAZ, ceftazidime; FEP, cefepime; IPM, imipenem; TZP, piperacillin-tozobactam; CHL, chloramphenicol; MIN, minocycline; SXT, trimethoprim-sulfamethoxazole; CIP, ciprofloxacin.